MedTrace Logo

Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit

NCT06434935 · Status: ENROLLING_BY_INVITATION · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-12-10

No results posted yet for this study

Summary

The Vascudyne Coronary Artery Bypass Study (VCAB-1) is an initial safety and feasibility study of the Vascudyne, Inc. Coronary Artery Bypass Conduit (CAB A) for bypass of stenosed native coronary arteries in patients undergoing coronary artery bypass surgery.

Conditions

Interventions

COMBINATION_PRODUCT

CABA

Coronary Bypass

Sponsors & Collaborators

  • Vascudyne, Inc.

    lead INDUSTRY

Principal Investigators

  • Adrian Ebner, MD · Italian Hospital Asuncion Paraguay

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-13
Primary Completion
2026-08-31
Completion
2026-08-31
FDA Drug
Yes
FDA Device
Yes

Countries

  • Paraguay

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06434935 on ClinicalTrials.gov